Laura Moreno

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

Anja Seckinger, Jose Antonio Delgado, Samuel Moser et al. · Cancer Cell · 2017 · 305 citations · Full text

Hematological Malignancy, Cancer Immunosurveillance, Multiple Myeloma Treatment +8

The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma

Laura Moreno, Cristina Pérez, Aintzane Zabaleta et al. · Clinical Cancer Research · 2019 · 204 citations · Full text

A simple flow-cytometry method to evaluate peripheral blood contamination of bone marrow aspirates

José Antonio Delgado, Francisco Guillén‐Grima, Cristina Moreno et al. · Journal of Immunological Methods · 2016 · 37 citations

Laboratory Hematology, Medicine, Bioanalysis +12

Myc-Related Mitochondrial Activity as a Novel Target for Multiple Myeloma

Alejandra Ortiz-Ruiz, Yanira Ruiz‐Heredia, María Luz Morales et al. · Cancers · 2021 · 20 citations · Full text

Hematological Malignancy, Mitochondrial Function, Mitochondrial Activity +13

Critical Analysis on the Mechanism of Action (MoA) of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma (MM)

Laura Moreno, Aintzane Zabaleta, Diego Alignani et al. · Blood · 2016 · 16 citations